INTERNATIONAL PATENT: POOLBEG PHARMA (UK) LIMITED FILES APPLICATION FOR "P38 MAP KINASE INHIBITOR FOR USE IN THE TREATMENT OF INFLAMMATION"

GENEVA, May 12 -- POOLBEG PHARMA (UK) LIMITED (40 Bank StreetFloor 24London Greater London E14 5NR) filed a patent application (PCT/GB2024/052759) for "P38 MAP KINASE INHIBITOR FOR USE IN THE TREATMENT OF INFLAMMATION" on Oct 30, 2024. With publication no. WO/2025/093869, the details related to the patent application was published on May 08, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): TREMBLE, Liam Freil (c/o Poolbeg Pharma (UK) Limited40 Bank StreetFloor 24London Greater London E14 5NR)

Abstract: A method of treating or preventing inflammation in a human patient in need thereof, comp...